• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素 B 从可生物降解的聚(乳酸-共-乙醇酸)纳米粒中的载药和释放。

Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.

机构信息

Pharmaceutics Division, Central Drug Research Institute (CSIR), M. G. Marg, Lucknow 226001, India.

出版信息

J Biomed Nanotechnol. 2011 Feb;7(1):118-20. doi: 10.1166/jbn.2011.1230.

DOI:10.1166/jbn.2011.1230
PMID:21485832
Abstract

Amphotericin B (AmB)-loaded poly(lactic-co-glycolic acid, PLGA) nanoparticles (NP) were prepared by solvent displacement. NP of size 160.7 +/- 10.45 nm, with a polydispersity index of 0.093 +/- 0.012 and a zeta-potential of -15.5 +/- 7.2 mV had satisfactory drug entrapment efficiency (42.5 +/- 6.41%). Biphasic drug release characterized by an initial burst followed by subsequent sustained release was observed. Applicability against visceral leishmaniasis and cancer is under investigation.

摘要

两性霉素 B(AmB)负载的聚乳酸-共-羟基乙酸(PLGA)纳米粒(NP)通过溶剂置换法制备。所得 NP 的粒径为 160.7 ± 10.45nm,多分散指数为 0.093 ± 0.012,ζ 电位为-15.5 ± 7.2mV,具有令人满意的药物包封效率(42.5 ± 6.41%)。观察到具有初始突释随后持续释放特征的两相药物释放。其对内脏利什曼病和癌症的适用性正在研究中。

相似文献

1
Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.两性霉素 B 从可生物降解的聚(乳酸-共-乙醇酸)纳米粒中的载药和释放。
J Biomed Nanotechnol. 2011 Feb;7(1):118-20. doi: 10.1166/jbn.2011.1230.
2
Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.可生物降解聚合物纳米粒子的合成及其在结核病中的控释药物传递。
J Biomed Nanotechnol. 2011 Feb;7(1):150-1. doi: 10.1166/jbn.2011.1244.
3
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.两性霉素B纳米颗粒的口服给药:大鼠体内的抗真菌活性、生物利用度及毒性
Drug Deliv. 2017 Nov;24(1):40-50. doi: 10.1080/10717544.2016.1228715.
4
Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.与静脉注射两性霉素B(商品名:Fungizone)相比,可生物降解的纳米颗粒提高了两性霉素B的口服生物利用度,并显示出更低的肾毒性。
Pharm Res. 2009 Jun;26(6):1324-31. doi: 10.1007/s11095-009-9841-2. Epub 2009 Feb 13.
5
Enhanced cellular uptake and biodistribution of a synthetic cannabinoid loaded in surface-modified poly(lactic-co-glycolic acid) nanoparticles.表面修饰的聚乳酸-羟基乙酸共聚物纳米载体制备的合成大麻素的细胞摄取和体内分布增强。
J Biomed Nanotechnol. 2014 Jun;10(6):1068-79. doi: 10.1166/jbn.2014.1806.
6
Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.载有双氯芬酸钠的 Eudragit® L100 和 Eudragit® L100-PLGA 纳米粒的配方和体外特性研究。
AAPS PharmSciTech. 2010 Sep;11(3):1250-6. doi: 10.1208/s12249-010-9489-6. Epub 2010 Aug 10.
7
Self-aggregated nanoparticles based on amphiphilic poly(lactic acid)-grafted-chitosan copolymer for ocular delivery of amphotericin B.基于两亲性聚乳酸接枝壳聚糖共聚物的自聚集纳米粒用于两性霉素 B 的眼部递药。
Int J Nanomedicine. 2013;8:3715-28. doi: 10.2147/IJN.S51186. Epub 2013 Sep 27.
8
Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.改良的纳米沉淀法制备阿糖胞苷载 PLGA 纳米粒。
AAPS PharmSciTech. 2010 Sep;11(3):1456-65. doi: 10.1208/s12249-010-9519-4. Epub 2010 Sep 15.
9
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.用于更昔洛韦立体异构二肽前药持续释放的基于纳米颗粒的局部眼用制剂。
Drug Deliv. 2016 Sep;23(7):2399-2409. doi: 10.3109/10717544.2014.996833. Epub 2015 Jan 7.
10
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.基于可生物降解聚合物的载蛋白缓释纳米颗粒的制备、表征及体外评价
Int J Nanomedicine. 2008;3(4):487-96. doi: 10.2147/ijn.s3938.

引用本文的文献

1
PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices.PLGA 纳米粒作为治疗利什曼病的新型药物递送系统:当前实践综述。
Curr Med Chem. 2024;31(39):6371-6392. doi: 10.2174/0929867331666230823094737.
2
Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application.用于临床口服的两性霉素 B 的潜在基于脂质的策略。
Drug Deliv. 2023 Dec;30(1):2161671. doi: 10.1080/10717544.2022.2161671.
3
Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis-An updated review.
当前化疗的局限性以及基于纳米制剂的两性霉素B用于内脏利什曼病治疗的未来——最新综述
Front Bioeng Biotechnol. 2022 Dec 14;10:1016925. doi: 10.3389/fbioe.2022.1016925. eCollection 2022.
4
Design of amphotericin B oral formulation for antifungal therapy.用于抗真菌治疗的两性霉素B口服制剂的设计
Drug Deliv. 2017 Nov;24(1):1-9. doi: 10.1080/10717544.2016.1225852.
5
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B.通过将一氧化氮靶向巨噬细胞胞质溶胶来补充宿主反应,在内脏利什曼病的仓鼠模型中是有效的,并且增强了两性霉素B的疗效。
Int J Parasitol Drugs Drug Resist. 2016 Aug;6(2):125-32. doi: 10.1016/j.ijpddr.2016.01.001. Epub 2016 Jan 14.
6
Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.载有两性霉素B的TPGS-b-(PCL-ran-PGA)纳米颗粒的抗真菌活性增强。
Int J Clin Exp Med. 2015 Apr 15;8(4):5150-62. eCollection 2015.
7
Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.含姜黄素微细胞对模型动物肝细胞癌的化疗潜力
Int J Nanomedicine. 2014 Mar 3;9:1139-52. doi: 10.2147/IJN.S34668. eCollection 2014.
8
Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection.评估 cubosomal 纳米粒作为口服 delivery 两性霉素 B 治疗真菌感染的潜力。
Int J Nanomedicine. 2014;9:327-36. doi: 10.2147/IJN.S54967. Epub 2014 Jan 6.